Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Mar 1995, 654-657, Vol 33, No. 3
KK Young, JJ Archer, O Yokosuka, M Omata and RM Resnick
Many of the current reverse transcription (RT)-PCR assays for the detection
of hepatitis C virus (HCV) RNA are multistep processes which use multiple
enzymes and buffers. The assays are also often suboptimal, requiring nested
amplification to achieve the desired levels of sensitivity. As a result,
these assays are cumbersome and prone to false-positive results. The
susceptibility to contamination is further aggravated by the lack of
carryover controls. We have previously reported the development of a
combined RT-PCR assay for HCV RNA detection which is sensitive and simple
to perform. We have since successfully integrated dUTP-uracil-N-glycosylase
carryover prevention into the combined assay. Restriction of as much as 0.5
microliter of deoxyuridine-containing amplification products has been
achieved. The performance of the improved combined assay was compared
directly with conventional nested RT-PCR and antibody detection. The
combined assay was found to have sensitivity similar to that of nested
RT-PCR in detecting HCV RNA from HCV antibody-positive specimens. In an
analysis of hepatitis B virus antibody-positive specimens, nested
amplification had false-positive rates ranging from 8 to 31%, while no
false-positive results were seen with the combined assay. In comparison
with serological methods, the combined assay had specificity and
sensitivity of 100 and 95%, respectively.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing
Department of Infectious Diseases, Roche Molecular Systems, Inc., Alameda, California 94501, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|